141 related articles for article (PubMed ID: 37680968)
21. Regulated in development and DNA damage 1 is necessary for hyperglycemia-induced vascular endothelial growth factor expression in the retina of diabetic rodents.
Dennis MD; Kimball SR; Fort PE; Jefferson LS
J Biol Chem; 2015 Feb; 290(6):3865-74. PubMed ID: 25548280
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation.
Choo AY; Yoon SO; Kim SG; Roux PP; Blenis J
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17414-9. PubMed ID: 18955708
[TBL] [Abstract][Full Text] [Related]
23. 4E-BP1 Protects Neurons from Misfolded Protein Stress and Parkinson's Disease Toxicity by Inducing the Mitochondrial Unfolded Protein Response.
Dastidar SG; Pham MT; Mitchell MB; Yeom SG; Jordan S; Chang A; Sopher BL; La Spada AR
J Neurosci; 2020 Nov; 40(45):8734-8745. PubMed ID: 33046555
[TBL] [Abstract][Full Text] [Related]
24. Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells.
Bhat M; Yanagiya A; Graber T; Razumilava N; Bronk S; Zammit D; Zhao Y; Zakaria C; Metrakos P; Pollak M; Sonenberg N; Gores G; Jaramillo M; Morita M; Alain T
Oncotarget; 2017 Aug; 8(31):50542-50556. PubMed ID: 28881582
[TBL] [Abstract][Full Text] [Related]
25. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.
Zhang D; Contu R; Latronico MV; Zhang J; Rizzi R; Catalucci D; Miyamoto S; Huang K; Ceci M; Gu Y; Dalton ND; Peterson KL; Guan KL; Brown JH; Chen J; Sonenberg N; Condorelli G
J Clin Invest; 2010 Aug; 120(8):2805-16. PubMed ID: 20644257
[TBL] [Abstract][Full Text] [Related]
26. The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway.
Talos DM; Sun H; Zhou X; Fitzgerald EC; Jackson MC; Klein PM; Lan VJ; Joseph A; Jensen FE
PLoS One; 2012; 7(5):e35885. PubMed ID: 22567115
[TBL] [Abstract][Full Text] [Related]
27. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator.
Shuda M; Kwun HJ; Feng H; Chang Y; Moore PS
J Clin Invest; 2011 Sep; 121(9):3623-34. PubMed ID: 21841310
[TBL] [Abstract][Full Text] [Related]
28. New insights into 4E-BP1-regulated translation in cancer progression and metastasis.
Wang J; Ye Q; She QB
Cancer Cell Microenviron; 2014; 1(5):. PubMed ID: 26005705
[TBL] [Abstract][Full Text] [Related]
29. Cell type-specific control of protein synthesis and proliferation by FGF-dependent signaling to the translation repressor 4E-BP.
Ruoff R; Katsara O; Kolupaeva V
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7545-50. PubMed ID: 27313212
[TBL] [Abstract][Full Text] [Related]
30. mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3.
Dodd KM; Yang J; Shen MH; Sampson JR; Tee AR
Oncogene; 2015 Apr; 34(17):2239-50. PubMed ID: 24931163
[TBL] [Abstract][Full Text] [Related]
31. Mechanistic Target of Rapamycin Complex 1 (mTORC1) and mTORC2 as Key Signaling Intermediates in Mesenchymal Cell Activation.
Walker NM; Belloli EA; Stuckey L; Chan KM; Lin J; Lynch W; Chang A; Mazzoni SM; Fingar DC; Lama VN
J Biol Chem; 2016 Mar; 291(12):6262-71. PubMed ID: 26755732
[TBL] [Abstract][Full Text] [Related]
32. Reappraisal to the study of 4E-BP1 as an mTOR substrate - A normative critique.
Batool A; Aashaq S; Andrabi KI
Eur J Cell Biol; 2017 Jun; 96(4):325-336. PubMed ID: 28427795
[TBL] [Abstract][Full Text] [Related]
33. Nuclear-targeted 4E-BP1 is dephosphorylated, induces nuclear translocation of eIF4E, and alters mRNA translation.
Takahashi S; Shibutani S; Iwata H
Exp Cell Res; 2022 Sep; 418(1):113246. PubMed ID: 35697076
[TBL] [Abstract][Full Text] [Related]
34. Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity.
Tsai S; Sitzmann JM; Dastidar SG; Rodriguez AA; Vu SL; McDonald CE; Academia EC; O'Leary MN; Ashe TD; La Spada AR; Kennedy BK
J Clin Invest; 2015 Aug; 125(8):2952-64. PubMed ID: 26121750
[TBL] [Abstract][Full Text] [Related]
35. Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency.
Li S; Sonenberg N; Gingras AC; Peterson M; Avdulov S; Polunovsky VA; Bitterman PB
Mol Cell Biol; 2002 Apr; 22(8):2853-61. PubMed ID: 11909977
[TBL] [Abstract][Full Text] [Related]
36. mTOR-mediated inactivation of 4E-BP1, an inhibitor of translation, precedes cartilage degeneration in rat osteoarthritic knees.
Katsara O; Kolupaeva V
J Orthop Res; 2018 Oct; 36(10):2728-2735. PubMed ID: 29761560
[TBL] [Abstract][Full Text] [Related]
37. Blocking eukaryotic initiation factor 4F complex formation does not inhibit the mTORC1-dependent activation of protein synthesis in cardiomyocytes.
Huang BP; Wang Y; Wang X; Wang Z; Proud CG
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H505-14. PubMed ID: 19074679
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of mammalian target of rapamycin (mTOR) signalling in C2C12 myoblasts prevents myogenic differentiation without affecting the hyperphosphorylation of 4E-BP1.
Willett M; Cowan JL; Vlasak M; Coldwell MJ; Morley SJ
Cell Signal; 2009 Oct; 21(10):1504-12. PubMed ID: 19481146
[TBL] [Abstract][Full Text] [Related]
39. The changing role of mTOR kinase in the maintenance of protein synthesis during human cytomegalovirus infection.
Clippinger AJ; Maguire TG; Alwine JC
J Virol; 2011 Apr; 85(8):3930-9. PubMed ID: 21307192
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the Raptor/4E-BP1 interaction by chemical cross-linking coupled with mass spectrometry analysis.
Coffman K; Yang B; Lu J; Tetlow AL; Pelliccio E; Lu S; Guo DC; Tang C; Dong MQ; Tamanoi F
J Biol Chem; 2014 Feb; 289(8):4723-34. PubMed ID: 24403073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
